Missense, nonsense and frameshift mutations in the collagen X gene (COL10A1) result in metaphyseal chondrodysplasia type Schmid (MCDS). Complete degradation of mutant COL10A1 mRNA by nonsensemediated decay in human MCDS cartilage implicates haploinsufficiency in the pathogenesis for nonsense mutations in vivo. However, the mechanism is unclear in situations where the mutant mRNA persist. We show that nonsense/frameshift mutations can elicit a gain-of function effect, affecting chondrocyte differentiation in the growth plate. In a MCDS proband, heterozygous for a p.Y663X nonsense mutation, the growth plate cartilage contained 64% wild-type and 36% mutant mRNA and the hypertrophic zone was disorganized and expanded. The in vitro translated mutant collagen X chains, which are truncated, were misfolded, unable to assemble into trimers, and interfered with the assembly of normal α1(X) chains into trimers. Unlike Col10a1 null mutants, transgenic mice (FCdel) bearing the mouse equivalent of a human MCDS p.P620fsX621 mutation, displayed typical characteristics of MCDS with disproportionate shortening of limbs and early onset coxa vara. In FCdel mice, the degree of expansion of the hypertrophic zones was transgene-dosage dependent, being most severe in mice homozygous for the transgene.
INTRODUCTION
In the development of the mammalian skeleton, differentiation and linear growth is mediated by the growth plate cartilage located at the ends of growing bones via endochondral ossification, a highly coordinated differentiation process during which bone replaces calcified cartilage. This programme of chondrocyte differentiation, proliferation, maturation and hypertrophy is controlled by a complex network of regulatory molecules and cell-extracellular matrix (ECM) interactions, which, when disrupted results in chondrodysplasia. Metaphyseal chondrodysplasia, type Schmid (MCDS, MIM #156500) is an autosomal dominant skeletal dysplasia. Affected individuals are clinically normal at birth but after they start walking, they develop disproportionate short stature which is due to progressive shortening and bowing of the femora and tibiae as well as to shortening and sagging of the femoral necks (coxa vara). The humeri, radii and ulnae are also shorter but are not bowed, whereas the craniofacial and spinal skeleton are relatively normal (1, 2) . The shortening and deformities of the long bones are due to impaired function of the thickened and irregular growth plates. Histological studies of a porcine model of MCDS show a thickened and disorganized hypertrophic zone of the growth plate (3).
Individuals with MCDS are usually heterozygous for mutations in the collagen X gene, COL10A1. Collagen X is a short chain non-fibrillar collagen produced specifically by hypertrophic chondrocytes in the hypertrophic zone of mammalian growth plates. Each protein chain consists of a carboxyl-terminal non-collagenous domain (NC1), the main triple helical domain (COL1), an aminoterminal non-collagenous domain (NC2) and a signal peptide. Trimeric molecules of collagen X are assembled from the NC1 domain within the rough endoplasmic reticulum (ER). Strong hydrophobic interactions between the NC1 domains play a critical role in the alignment of the collagen X chains and stabilize the collagen X trimers, ensuring that the triple helix can nucleate and propagate correctly from the carboxyl-to amino-terminal end of the molecule. Triple helical molecules of collagen X, containing at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from the terminal NC1 and NC2 domains, are secreted by hypertrophic chondrocytes into the extracellular matrix.
The in vivo impact of MCDS COL01A1 mutations, comprising missense, nonsense and frameshift mutations, is poorly understood and both haploinsufficiency and dominant-negative mechanisms have been proposed. In human MCDS, forty of the forty-two reported mutations alter the NC1 domain while two alter the signal peptide cleavage site of the collagen X protein chain (2, 4, 5) . Haploinsufficiency has been implicated in the pathogenesis of human MCDS because mutant mRNAs were absent from the growth plate cartilage of two patients with MCDS with nonsense mutations p.Y632X (6) and p.W611X (7) as a result of premature termination codons. Nonsense-mediated decay of the mutant mRNAs was proposed to be the likely mechanism where the mutant message is preferentially degraded (8) , leaving only wild type mRNA for translation of reduced amounts of normal collagen X protein chains, which implicates COL10A1 haploinsufficiency. The two missense mutations altering the signal peptide cleavage site of collagen X were shown, by transfection of heterologous cells, to impair cleavage of the signal peptide and to result in persistent attachment of the mutant collagen X chains to the inner membrane of the ER (9) . In these examples it is likely that the mutant collagen X would not be secreted and may similarly result in haploinsufficiency for collagen X.
Haploinsufficiency for collagen X as a mechanism for MCDS is complicated because no true null mutations in COL10A1 have yet been identified in MCDS, and absence of collagen X in the mouse results in the abnormal distribution of matrix vesicles and matrix components in the growth plates of the null mice (10) and yields a very mild MCDS-like phenotype with late onset mild coxa vara, while heterozygous null mice are phenotypically normal (10) . Because the phenotypes of humans with MCDS due to mutations that yield premature termination codons are more severe than that of the collagen X null at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from mouse, it is unclear whether these differences are due to biomechanical and other differences between mouse and man, or whether the human MCDS phenotype is caused by additional mechanisms.
In vitro studies have shown that missense mutations can result in the formation of mutant homotrimers and mixed wild type and mutant heterotrimers (11) (12) (13) . In addition some nonsense or frameshift mutations (resulting in premature termination codons) of other genes result in only partial degradation of the mutant mRNAs (8, 14) . Thus, it is possible that in vivo, interference with the assembly of collagen X acts dominant-negatively resulting in poor or no secretion of mutant homo-and heterotrimers and reduced amounts of normal collagen X in the ECM. In the absence of mutant collagen X in the ECM, the phenotype could be attributed to haploinsufficiency for collagen X. However, if mutant collagen X is secreted to the ECM, there could be a dominant-negative effect on ECM structural properties. Interestingly, cellular transfection studies have shown that a MCDS COL10A1 frameshift mutation p.Y623fsX673, yielding truncated α1(X) chains with a misfolded NC1 domain were retained within the ER, where they stimulated the unfolded protein response (UPR) (15) . This finding raises an interesting possibility that even when mutant collagen X is not secreted, in vivo, an additional gain-offunction effect could be invoked. The MCDS phenotype may therefore be the outcome of both haploinsufficiency and gain-of-function.
To better understand the molecular mechanisms underlying human MCDS, we investigated the consequences of nonsense and frameshift mutations of COL10A1 in in vitro protein assembly studies, in human MCDS cartilage, and in a transgenic mouse model of MCDS. Mutations that produce human MCDS impaired the in vitro assembly of mutant homotrimers as well as of wild type and mutant heterotrimers. Trimerization of the wild type molecules was consistently reduced in vitro in the presence of the truncated mutant chains. Growth plate cartilage from a proband with MCDS due to a p.Y663X mutation contained wild type and mutant mRNAs and showed an expanded hypertrophic zone. Assembly
7

RESULTS
Phenotype of a human MCDS proband
A child (MCDS-18) was identified with typical features of MCDS (2). At 1.5 to 2 years of age, he developed progressive disproportionate short stature and angular deformities of the legs. By 13 years of age, his height z-score was -5.7 standard deviations. His limb shortening was rhizomelic in that the proximal portions of his limbs were shorter than the distal portions. His knee, ankle and wrist joints were enlarged. He had a lumbar lordosis due to flexion deformities of his hips; otherwise, his spine was clinically normal. Radiographs showed that the femora and tibiae were bowed and that their growth plates were wider, thicker and less regular than normal (Fig. 1A) . A skeletal survey showed similar growth plate changes in the proximal humerii and distal radii whereas the growth plates of the elbows, hands and spine appeared more normal. Radiographs also showed that the growth plates around the knees temporarily returned to a more normal appearance following surgical realignment of the legs and 6 weeks of non-weight bearing (Fig. 1B ). An iliac crest cartilage biopsy from the proband showed that the hypertrophic zone of the iliac growth plate was expanded and that the cellular architecture of the hypertrophic zone was disorganized (Fig. 1C) .
p.Y663X mutant mRNA in human MCDS growth plate cartilage
Direct sequencing of the amplified DNA product from exon 3 of the COL10A1 gene showed that the proband was heterozygous for a c.1989C>G mutation, representing a nonsense mutation, p.Y663X (Fig.   1D ). The relative level of normal to mutant COL10A1 mRNA in the proband's growth plate cartilage, determined by RT-PCR followed by Sfc-I cleavage (Fig. 1E ) and single nucleotide extension assay (Fig.   1F ), was about 0.64:0.36. The normal to mutant genomic DNA ratios were about 1:1. Therefore, approximately 50% of the expected amount of mutant mRNA was available to be translated into truncated α-chains. Negative impact of nonsense and frameshift mutations on in vitro collagen X assembly.
As the proband's cartilage sample was too small for protein analyses, the assembly of collagen X trimers was quantified in an in vitro cell-free translation assay (16) . The wt and two normal variant (p.G545R and p.V603M) α-chains had a mean in vitro trimerization efficiency of 61.3% (Table 1) . In contrast, the p.Y663X mutant α-chains did not produce detectable homotrimers (Fig. 1G) . The impact of the p.Y663X α-chains on trimerization of wt α-chains was assessed using wt:mutant transcript ratios of 0.64:0.36, as determined in vivo. The trimerization efficiency of wt α-chains was significantly reduced from 61.3%, when translated on its own, to 43.8% when it was translated in a 0.64:0.36 ratio with p.Y663X α-chains and further, to 31.5%, when the ratio was 1:1 (Table 1) . Similar results were obtained using reporter "wild type α1(X) chains" [helixΔ-α1(X)] to better differentiate "wt" and p.Y663X α-chains (supplemental Fig.   S1 ).
The quantitative in vitro effects of the truncated α1(X) chains produced by the p.W611X and p.Y632X mutations, that were associated with in vivo COL10A1 haploinsufficiency (6, 7) , and the effects of the frameshift p.Y623fsX673 and p.P620fsX621 mutations on wt α1(X)-chain trimer assembly were compared to the results achieved with p.Y663X α1(X)-chains ( Fig. 1G and Table 1 ). The results were similar for all of the truncated mutant α1(X)-chains tested. Thus, if the mutant mRNA is translated, the α1(X)-chains with truncated NC1 domains may have a dominant-negative effect in vivo and the impact may be dosage dependent.
Generation of transgenic mice expressing Col10a1 MCDS mutation
To address the mechanism for the pathogenesis of MCDS, we produced transgenic mice expressing a mouse Col10a1 transgene, Cdel, that was equivalent to one of the human frameshift mutations studied in our in vitro protein assembly assay -p.P620fsX621/c.1859delC (17) . All transgenes contained a 2 kb 5' flanking sequence (Fig. 2C) Fig. 2A) .
The effect of the Cdel and FCdel α1(X)-chains on mouse collagen X trimerization efficiency was first tested using the in vitro assembly assay using equivalent cDNA constructs. Consistent with our results in humans, the mouse wt and FColX α1(X)-chains assembled efficiently into trimers whereas Cdel and FCdel α-chains failed to produce detectable trimers ( FCdel α1(X)-chains on mouse wt α1(X)-chain assembly were similar to the effects we observed with the equivalent human mutation p.P620fsX621/c.1859delC (Fig. 1G ).
Three FColX founders were generated and all were phenotypically normal (data not shown).
Three transgenic founders were generated for each of the Cdel and FCdel transgenes. In two of the three Cdel founders, expression of the transgene was less than 25% of the expression of the endogenous gene.
The third founder, which expressed slightly higher levels of the transgene, was selected for the current study A consistent radiographic feature of human MCDS is the development of coxa vara, a reduction in the obtuse angle between the femoral neck and shaft (1). At 5 weeks of age, all transgenic lines showed small but statistically significant decreases in their femoral neck-shaft angles, indicating mild coxa vara (Supplemental Fig. S3 , Table 2 ). No statistical differences in these angles were detected between the control mouse lines (wt, Col10a1 +/-, Col10a1 -/-and FColX) at this age. Col10a1 -/-mice were previously
shown to develop late onset mild coxa vara at the age of 15-20 weeks (10).
Expansion of hypertrophic zone in growth plates of Cdel transgenic mice
At 10 days of age, histological analyses were undertaken of the proximal tibial and distal femoral growth plates as these showed the greatest radiographic change in human MCDS (2) . Sections were stained with 
Transgene product expressed in hypertrophic chondrocytes is retained intracellularly
Immunostaining for collagen X in the hypertrophic zone consistently showed more intracellular staining in FCdel +/-and FCdel +/+ mice in Col10a1 +/+ backgrounds than in the wt or FColX mice ( 
Intracellular retention of FCdel proteins activates the unfolded protein response
Intracellular retention of misfolded or unfolded proteins can induce ER-stress with activation of the UPR.
To determine whether the UPR was triggered in FCdel hypertrophic chondrocytes, we studied the expression of key transducers of the UPR. The molecular chaperone, BiP, is up-regulated in the UPR (18) and consistent with the presence of higher levels of unfolded proteins and induction of the UPR, there was more BiP in the hypertrophic chondrocytes in FCdel +/-and FCdel +/+ mice than in wt littermates, particularly in the lower hypertrophic region (Fig. 5A ).
During the UPR, activation of the Perk sensor allows the translation of Atf4, a bZIP transcription factor that induces the expression of the apoptotic gene Chop/Gadd153 (19, 20) . The levels of CHOP proteins were higher in FCdel +/-and FCdel +/+ than in wt hypertrophic cells (Fig. 5A ), but there was no detectable change in the extent of apoptosis in the growth plate (Supplemental Fig. S7 ). In the wt and 
Altered gene expression profile of terminal differentiated hypertrophic chondrocytes in FCdel mice
We hypothesized that the observed expansion of the hypertrophic zone was due to impaired terminal differentiation of FCdel +/+ and FCdel +/-hypertrophic chondrocytes. As wt proliferating chondrocytes enter and progress through hypertrophy, several genes are characteristically changed in preparation for the conversion to bone (23, 24 
DISCUSSION
The present study was undertaken to investigate the mechanisms operating in vivo in the pathogenesis of MCDS resulting from the introduction of premature termination codons into the region of the COL10A1 transcript that encodes the NCI domain of α1(X) collagen chains. By in vitro protein assembly assays, analysis of human MCDS tissue and mouse models, we have provided in vivo evidence that MCDS COL10A1 mutations, while resulting in some mRNA degradation, also exerted a gain-of-function effect on the growth plate which results in chondrodysplasia.
The proband MCDS-18, in the current study, was heterozygous for a p.Y663X mutation that produced truncated α1(X) chains lacking the last 18 amino acids of the NC1 domain. Iliac crest growth plate cartilage from the proband contained approximately 64% wt and 36% p.Y663X α1(X) mRNAs. We estimated that approximately 50% of the mutant mRNA was degraded, while the rest was translated into truncated α1(X) chains. Because the iliac crest cartilage sample was too small for protein analyses, we investigated the impact of these truncated chains in in vitro protein assembly assays.
These assays showed that the proband's p.Y663X α1(X)-chains did not form stable homotrimers and were unable to form stable heterotrimers with wt α1(X)-chains. Similar findings were observed for p.W611X and p.Y632X α1(X)-chains but these chains are not produced in human MCDS growth plate cartilage because of nonsense-mediated decay of the mutant mRNA (6,7). Two human MCDS frameshift mutations, p.Y623fsX673 and p.P620fsX621, similarly impaired trimer assembly although it is unknown whether mutant proteins were synthesized in vivo (16) . The proband and reported mutations, included within the current study, truncated the last β-strand H of the NC1 domain which is normally buried within the interior of the domain (25) . From the crystal structure, truncations within the β-strand H were predicted to prevent the folding of the NC1 subunits and their assembly into trimers, however, our current and previous in vitro assembly studies showed that the truncated α1(X)-chains interfered in a dominantnegative manner with the assembly of wt trimers. Although we did not identify the proximal interacting peptide sequences, it is likely that the interactions between the wt and mutant chains involved the conserved aromatic motif (26) F 589 -Y 601 within the NC1 domain. This motif, which is probably the initial site of interaction and registration of the α1(X)-chains, has been shown to be critical for the assembly of trimers (11).
It was of interest to note that while the mutant chains were unable to form "stable" trimers, their presence in co-translation studies showed a negative effect on the efficiency of wt chain trimerization.
The wt trimers that can be detected are held together by stronger hydrophobic interaction via the NC1 domain (16) . Thus, the negative effect is likely to result from "unstable/non-productive" interactions between wt and mutant chains that can not be detected using SDS polyacrylamide gel electrophoresis, and the effect is a reduced pool of wt chains forming stable trimers, consistent with a dominant-negative mechanism in which mutant α1(X) chains interfere with wild type collagen X assembly.
Previous transfection studies provided insights into the disease mechanisms that may occur in vivo if hypertrophic chondrocytes synthesized α1(X) chains with truncated NC1 domains. Transient transfections of heterologous cells with the frameshift mutations p.Y623fsX673 and p.P620fsX621 yielded small amounts of mutant α1(X) collagen chains that were retained within the cells (16) . The truncated α1(X) chains were sensitive to limited pepsin digestion, indicating that they were unable to form correctly assembled triple helical collagen X molecules (16) . Stable transfection of the p.Y623fsX673 mutation in heterologous cells confirmed that the mutant collagen chains were retained with the cells (27, 28) . Cells expressing these mutant α1(X) chains had significantly increased amounts of BiP and the spliced form of Xbox DNA-binding protein mRNA (Xbp1), two key markers of the UPR (18, 29) . Unfortunately, we were unable to show increased intracellular wt chains experimentally because while the Flag antibody was able to specifically identify the FCdel α1(X) chains in the ER, our collagen X antibody was unable to distinguish the wt α1(X) chains from the FCdel α1(X) chains in the ER.
Previous studies of Col10a1-null mice showed that the absence of collagen X in the extracellular matrix did not result in abnormal chondrocyte maturation (10) . Consequently, the abnormal hypertrophic chondrocyte maturation observed in the FCdel mice probably resulted from the adverse effects of the mutant protein retained within the ER. In agreement with previous transfection studies, the retained FCdel α1(X) chains activated an ER-stress response.
Activation of ER-stress responses due to protein misfolding has been implicated in the pathogenesis of many diseases [see review by (30) ]. In FCdel mice, the hypertrophic chondrocytes had elevated levels of BiP, Chop and Xbp1 s , which are key markers of ER-stress. Xbp1 s is a potent transcription factor and is known to be correlated with the level of ER stress (31, 32) . Its expression in the FCdel mice showed that the level of ER stress increased with transgene dosage. In the FCdel mice, ERstress due to retained misfolded α1(X) chains appeared to be the cause of the abnormal differentiation of the hypertrophic cells, thickening of the hypertrophic zone and impaired longitudinal bone growth.
Hypertrophic cells in the upper part of the hypertrophic zone expressed typical phenotypic markers.
However, rather than undergoing apoptosis, as observed in wt growth plates, the hypertrophic cells mutations. These findings suggested that the lower limb phenotype was more severe in the human probands than in the FCdel mice. The severity of the radiographic changes in the human probands appeared to be related to weight bearing and to the intrinsic growth rates of the different growth plates.
For example, the non-weight bearing arms did not show any bowing of the long bones. Thickening and irregularity of the growth plates were observed in the fast growing proximal humeri and distal radii but not in slow growing distal humerii, hands or in the proximal radii and ulnae. The adverse effects of weight bearing were likely to account for the post natal onset of leg deformities and for the more severe radiographic changes in the legs than in the arms. The radiographic appearance of the distal femora and proximal tibiae were modulated in proband MCDS-18 by realignment surgery and 6 weeks of non-weight bearing. During this 6 week period, the growth plates around the knees became normal in thickness and developed a well defined metaphyseal layer of trabecular bone but reverted to their preoperative appearances after the resumption of weight bearing. The mechanisms involved in these changes are unknown but may involve the modulation of differentiation of the hypertrophic zone. It is probable, based on the findings in the FCdel mouse that weight bearing adds to the stress, leading to thickening of the hypertrophic zone with abnormal differentiation of the hypertrophic chondrocytes and delayed endochondral bone formation. Removal of the weight bearing reduces stress, enabled differentiation to proceed more normally, and a more "normal" transition to the trabecular bone in the metaphysis.
Collagen X null mice have mild coxa vara, one of the many characteristics MCDS (10), and it is late-onset in contrast to the early-onset, moderate form of MCDS in the FCdel mice. This supports a dominant mechanism for MCDS mutations which disrupt collagen X assembly as opposed to complete absence of protein. Similar differences may also apply to humans with MCDS depending on whether mutant α1(X) chains are synthesized or not. The proband in the present study had the clinical onset of MCDS at the early age of 1.5-2 years. It is likely that the severity and age of onset of his MCDS reflected the dominant effects of the p.Y663X α1(X) chains. The proband with the mutation that was used to create the FCdel mice was reported also to have typical MCDS with similar onset at about 2 years of age and similar radiographic severity to our proband. In contrast, the reported probands with COL10A1 haploinsufficiency due to p.Y632X (6) and p.W611X (7) Genomic DNA was extracted from whole blood using QIAmp DNA Blood Mini Kit (Qiagen) for PCR amplification of the COL10A1 gene for sequencing. mRNA was prepared using the Dynabeads mRNA Purification Kit (Dynal) from total RNA extracted from frozen sections of the hypertrophic zones of iliac crest cartilage samples using the Trizol reagent (Invitrogen). The relative levels of normal and mutant collagen X mRNA were determined by RT-PCR followed by restriction mapping or primer extension with nucleotide specific chain termination. mM ddGTP. The extended products were resolved on a 10% denaturing polyacrylamide gel, and radioactive fragments quantified using a PhosphorImager 400E (Molecular Dynamics).
Mouse Col10a1 mutagenesis
A human MCDS mutation, c.1859delC (4, 17) , was created at the equivalent site in the mouse Col10a1 gene by site-directed mutagenesis using overlapping PCR as previously described (36) . Given that the mouse sequence differs to the human sequence around the region of the C base deletion, a primer, 5' TGTATAAGAATGGCACCCTGTAATGTACAC 3', corresponding to the human sequence was used to introduce the mutation, to produce the predicted outcome of p.P620fsX621 (17) , representing a frameshift at amino acid position 620, followed with a termination codon, TAA (underlined in the primer sequence), at position 621. The resultant Cdel α1(X) chain is shorter by 60 amino acids.
The PCR product containing the mutation was cloned into a 10.5kb fragment of the mouse Col10a1 gene to generate the Cdel transgene containing 2 kb of the 5' and 1.3kb of 3' flanking sequence after exon 3 (Fig. 2C) . The Cdel mutation was also created in a Flag-epitope tagged Col10a1 gene (FColX) to produce the FCdel transgene. FColX transgene contains the Flag-epitope sequence (5'-GACGACGATGACAAGCTTGCGGGCCCA-3') inserted in-frame into exon 2 at nucleotide position 741 (numbered from the start of transcription) of the mouse Col10a1 gene (Fig. 2A) .
Generation and genotyping of transgenic mice
Cdel and FCdel and FColX transgenic mouse founders were generated by pronuclear injection of Cdel, FCdel and FColX transgenes, respectively, into one-cell CBA/C57BL6 F1-hybrid zygotes using standard protocols (37) . FCdel and FColX transgenic mice were mated with F1 mice (129SVJ/C57BL6) for several generations to produce mice containing a single integration site for the transgene, and these mice were used in all subsequent analyses. FCdel and FColX transgenic mice were crossed with Col10a1 -/-mice (10) containing null alleles for the Col10a1 gene, to produce compound heterozygous, which were inter- 
Southern-blot analysis
The number of transgenes integration site(s) in the transgenic founders/lines were analyzed by Southernblot analysis using Bam-HI-digested genomic DNA hybridized with a [α-32 P]-dCTP labeled 2,073 bp probe (Fig. 1D) 
Radiological analysis for MCDS characteristics in mice
Radiological images were taken for 5-and 10-week-old mice. All images were taken under identical exposure and radiation energy (24kV/25mA) using high resolution Kodak mammography X-ray film (Kodak Diagnostic film Min-R TM H MRH-1) and a General Electric X-ray machine (Senograph 600T Senix HF, General Electric, USA). Mice were anaesthetized to facilitate radiography and all were positioned such that the greater trochanters of both femurs were clearly seen on the radiographs. On the radiographs, axes for the femur neck and shaft were drawn, and the obtuse angles between these two axes were measured as previously described (10) . The body length of each mouse was measured from the tip of the nose to the second caudal vertebral centra. Tibial bone length was also measured. Measurements were analyzed for statistical differences by the Mann-Whitney's U test and a two-tailed p-value <0.05 is taken as statistically significant.
Histochemistry and immunohistochemistry
Limbs were fixed in freshly prepared 4% (w/v) paraformaldehyde, and demineralized in 0.5M EDTA (pH Sections were counter stained with hematoxylin.
In situ hybridization
In-situ hybridization was performed as previously described (38) , using [
S]UTP-labeled ribopobes for
Col10a1 and Col2a1 (38) , the PTHrP receptor (Ppr) and Opn (from H. Kronenberg).
Cell-Free translation and in vitro trimer assembly
A plasmid pFX1, containing the full-length human collagen X cDNA was used as a template to generate the mutant plasmids Y623fsX673, Y632X, P620fsX621 and W611X, as well as the polymorphisms G545R and V603M. The mutations were amplified from patient genomic DNA, and subcloned into pFX1. Transcription and translation were performed using the TNT-coupled transcription and translation system (Promega) to assess trimerization, as previously described (16) . The translated products were analyzed using a 4-15% SDS-PAGE (Criterion gels, BioRad). Mouse wt, FColX, Cdel and FCdel fulllength cDNA constructs were generated in pBluescript II SK (-) (Strategene). Expression and trimerization were similarly assessed using the TNT-coupled transcription and translation system (Promega) (16) , and the translated products analyzed using a 7.5% (w/v) SDS-PAGE. [ 35 S]-Met labeled proteins quantified using a phosphorImager 400E (Molecular Dynamics).
Protein truncation test
Cell free transcription and translation was also used to rapidly screen for homozygous by SDS polyacrylamide gel electrophoresis and imaged using the PhosphorImager (Molecular Dynamics).
The 40 kDa (product from the endogenous Col10a1 allele) and 34 kDa (product from the FCdel transgene) products were quantified and their relative ratio determined following adjustment of the number of methionine residues, to identify mice that are heterozygous or homozygous for the FCdel allele.
This method was also used to estimate the copy number of the transgene, and for determining the relative levels of wt and FCdel mRNA in explant cultures in the presence or absence of 100 μg/ml cycloheximide (Sigma Chemical Co., St. Louis, MO). The products in lanes 4-6 were digested with Sfcl (+). In the proband's cartilage sample, 65% of the α1(X) product was wild type and 35% was mutant. (F) Quantification of wild type α1(X) and mutant p.Y663X-α1(X) mRNAs in the hypertrophic zone using primer extension analysis. Primer extension of the wild type and mutant templates yielded 32 nt and 25 nt products, respectively. The products were resolved by 10% PAGE and quantified by a phosphoimager. Lane 1, wild type α1(X) cDNA plasmid; 
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